Ven-A-Care chases down Medicare defrauders, collects bounties

Photo of a medicare card.

Ven-a-Care busts drug companies for Medicare fraud. CC by http://www.medicare.gov/Wikimedia Commons

It’s not every day a small pharmacy generates $168.7 million in annual revenue., but the Los Angeles Times reports that the specialty pharmacy Ven-A-Care of Florida Keys, Inc., is no mere small pharmacy. The company acts as a whistle-blower that reports the misdeeds of pharmaceutical companies that overbill Medicare and Medicaid. While the company has been called a “professional bounty-seeker” by critics, the truth is is that tens of millions of taxpayer dollars are at stake.

Purpose of Ven-A-Care

In its whistle-blower capacity, Ven-A-Care researches the price it pays for drugs versus those reported by big pharmaceuticals to the federal government for reimbursement purposes. Ven-A-Care is able to file a lawsuit for the U.S. government if there is a discrepancy.

For example, a 2005 case involved a 1-gram vial of vancomycin. Medi-Cal was charged $58.37 for it while pharmacies were charged $6.29 each. In another case, the medication atenolol charged Medi-Cal $70.30 while pharmacies only paid $3.05 for 50-milligram tablets. These examples are just the tip of the iceberg, says that Los Angeles Times. The State of California has recovered at least $95 million of late, thanks to Ven-A-Care’s efforts.

“I think Ven-A-Care has played a predominant role in alerting state and federal governments about … fraud,” said California Supervising Deputy Attorney General Nicholas Paul.

How the Ven-A-Care cases work

Since 2000, about 18 health insurance over-billing cases have been won by Ven-A-Care. While the small pharmacy has collected about $380 million in bounty funds, state and federal governments across the U.S. have pulled in about $2.2 billion.

“(Ven-A-Care is) cleaning up a huge cesspool,” said Nevada attorney and former Medicaid fraud investigator L. Timothy Terry. “Without their efforts, taxpayers would be gouged out of I don’t know how much money.”

Making sure payments have a cap

Insiders like former federal healthcare fraud investigator Michael Loucks believe that companies like Ven-A-Care are taking advantage of a near-limitless jackpot system. Now a defense attorney, Loucks told the Times that a $2 million cap should be instituted, large enough to still encourage whistle-blowers, but small enough to keep the government’s expense under control.

Jin Breen is the attorney for Ven-A-Care. He says that the cap won’t work. A big return has to be paid out because of the amount of legal costs that come when pursuing big pharmaceuticals.

Citations

Los Angeles Times

Medicare fraud hurts U.S. taxpayers

Other recent posts by bryanh